Therapeutic approaches to peripheral neuropathy based on neuroactive steroids

Expert Review of Neurotherapeutics

Volumn 6, Issue 8, 2006, Pages 1121-1125

  Melcangi, Roberto C ^a   Garcia Segura, Luis M ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTO CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4' CHLORODIAZEPAM; 6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; ANDROSTANOLONE; ANTIINFECTIVE AGENT; BENZODIAZEPINE RECEPTOR; BICUCULLINE; ESTRADIOL; GLUCOCORTICOID; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LIGAND; LITHIUM; MESSENGER RNA; MIFEPRISTONE; MUSCIMOL; MYELIN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; NEUROSTEROID; PRASTERONE; PREGNENOLONE; PROGESTERONE; SSR 180575; STEROID; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANALGESIA; BRAIN INJURY; DRUG EFFECT; EDITORIAL; GENE EXPRESSION; HORMONE SYNTHESIS; NERVE INJURY; NEUROPROTECTION; NONHUMAN; PERIPHERAL NEUROPATHY; PROTEIN EXPRESSION;

GONADAL STEROID HORMONES; HUMANS; INCIDENCE; PERIPHERAL NERVOUS SYSTEM DISEASES; PROGESTERONE;

EID: 33747153332     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.6.8.1121     Document Type: Editorial

References (20)

1. Melcangi RC, Panzica GC. Neuroactive steroids: old players in a new game. Neuroscience 138(3), 733-739 (2006).
2. Azcoitia I, Leonelli E, Magnaghi V, Veiga S, Garcia-Segura LM, Melcangi RC. Progesterone and its derivatives dihydroprogesterone and tetrahydroprogesterone reduce myelin fiber morphological abnormalities and myelin fiber loss in the sciatic nerve of aged rats. Neurobiol. Aging 24(6), 853-860 (2003).
3. Sereda MW, Meyer zu Horste G, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat. Med. 9(12), 1533-1537 (2003).
4. Leonelli E, Ballabio M, Consoli A, Roglio I, Magnaghi V, Melcangi RC. Neuroactive steroids: a therapeutic approach to maintain peripheral nerve integrity during neurodegenerative events. J. Mol. Neurosci. 28(1), 65-76 (2006).
5. Koenig HL, Schumacher M, Ferzaz B et al. Progesterone synthesis and myelin formation by Schwann cells. Science 268(5216), 1500-1503 (1995).
6. Melcangi RC, Azcoitia I, Ballabio M et al. Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves. Prog. Neurobiol. 71(1), 57-66 (2003).
7. Schumacher M, Guennoun R, Mercier G et al. Progesterone synthesis and myelin formation in peripheral nerves. Brain Res. Rev. 37(1-3), 343-359 (2001).
8. Chavez-Delgado ME, Gomez-Pinedo U, Feria-Velasco A et al. Ultrastructural analysis of guided nerve regeneration using progesterone- and pregnenolone-loaded chitosan prostheses. J. Biomed. Mater. Res. B Appl. Biomater. 74(1), 589-600 (2005).
9. Tanzer L, Jones KJ. Neurotherapeutic action of testosterone on hamster facial nerve regeneration: temporal window of effects. Horm. Behav. 45(5), 339-344 (2004).
10. Ayhan S, Markal N, Siemionow K, Araneo B, Simionow M. Effect of subepineurial dehydroepiandrosterone treatment on healing of transected nerves repaired with the epineurial sleeve technique. Microsurgery 23(1), 49-55 (2003).
11. Gudemez E, Ozer K, Cunningham B, Siemionow K, Browne E, Siemionow M. Dehydroepiandrosterone as an enhancer of functional recovery following crush injury to rat sciatic nerve. Microsurgery 22(6), 234-241 (2002).
12. Islamov RR, Hendricks WA, Jones RJ, Lyall GJ, Spanier NS, Murashov AK. 17β-estradiol stimulates regeneration of sciatic nerve in female mice. Brain Res. 943(2), 283-286 (2002).
13. Veiga S, Leonelli E, Beelke M, Garcia-Segura LM, Melcangi RC. Neuroactive steroids prevent peripheral myelin alterations induced by diabetes. Neurosci. Lett. 402(1-2), 150-153 (2006).
14. Melcangi RC, Cavarretta IT, Ballabio M et al. Peripheral nerves: a target for the action of neuroactive steroids. Brain Res. Rev. 48(2), 328-338 (2005).
15. McMurray R, Islamov R, Murashov AK. Raloxifene analog LY117018 enhances the regeneration of sciatic nerve in ovariectomized female mice. Brain Res. 980(1), 140-145 (2003).
16. Benmessahel Y, Troadec J-D, Cadepond F et al. Downregulation of steroidogenic acute regulatory protein (StAR) gene expression by cyclic AMP in cultured Schwann cells. Glia 45(3), 213-228 (2004).
17. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neurophatology and neurological disorders. Neuroscience 138(3), 749-756 (2006).
18. Ferzaz B, Brault E, Bourliaud G et al. SSR180575 (7-chloro-N,N,5- trimethyl-4-oxo-3-phenyl-3,5-dihydro-4Hpyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair. J. Pharmacol. Exp. Ther. 301(3), 1067-1078 (2002).
19. Leonelli E, Yague JG, Ballabio M et al. Ro5-4864, a synthetic ligand of peripheral benzodiazepine receptor, reduces aging-associated myelin degeneration in the sciatic nerve of male rats. Mech. Ageing Dev. 126(11), 1159-1163 (2005).
20. Veiga S, Azcoitia I, Garcia-Segura LM. Ro5-4864, a peripheral benzodiazepine receptor ligand, reduces reative gliosis and protects hippocampal hilar neurons from kainic acid excitotoxicity. J. Neurosci. Res. 80(1), 129-137 (2005).